Biosystems ApS: Financial statements 2022
CVR: 41945729
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biosystems ApS (CVR 41945729) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -9,784 and a net result of DKK -957 compared with DKK -29,294 the year before. Equity in the 2022 report amounted to DKK 9,749. The solvency ratio was 39.4%.
- Gross Profit
- DKK -9,784
- Profit/Loss
- DKK -957
- Equity
- DKK 9,749
- Total Assets
- DKK 24,752
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10 t. | -957 | 10 t. | - |
| 2021 | - | -30 t. | -29 t. | 11 t. | - |
Keep an eye on Biosystems ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biosystems ApS has published its annual report for 2021. Gross profit came to DKK -30,085, and the net result was DKK -29,294.
As of July 31, 2022, Regnskabsfabrikanten A/S has stepped down as auditor of Biosystems ApS.
As of May 23, 2022, Regnskabsfabrikanten A/S has been appointed auditor of Biosystems ApS.
As of May 23, 2022, BUUS JENSEN I/S STATSAUTORISEREDE REVISORER has stepped down as auditor of Biosystems ApS.
About Biosystems ApS
Biosystems ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Jonas Jacob Husmer. The company is owned by Biosystems Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,477 and a net result of DKK -10,473 compared with DKK -9,083 the year before. Equity in the 2025 report amounted to DKK -7,752.